These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15308327

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Selective elimination of alloreactive donor lymphocytes by using TBI and cyclophosphamide].
    Chen BA, Dong WM, Ding JH, Sun XM, Deng XJ, Zhang Y, Bi YZ, Zhao G, Gao C, Sun YY, Wang J, Cheng J, Schmitt M, Schmitt A.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):332-6. PubMed ID: 17493342
    [Abstract] [Full Text] [Related]

  • 3. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB, Elkin G, Khitrin S, Slavin S.
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [Abstract] [Full Text] [Related]

  • 4. Effect of KRN7000 on induced graft-vs-host disease.
    Morecki S, Panigrahi S, Pizov G, Yacovlev E, Gelfand Y, Eizik O, Slavin S.
    Exp Hematol; 2004 Jul; 32(7):630-7. PubMed ID: 15246159
    [Abstract] [Full Text] [Related]

  • 5. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC, Song CW, Blazar BR, Vallera DA.
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [Abstract] [Full Text] [Related]

  • 6. Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.
    Yang I, Weiss L, Abdul-Hai A, Kasir J, Reich S, Slavin S.
    Cancer Res; 2005 Nov 01; 65(21):9735-40. PubMed ID: 16266994
    [Abstract] [Full Text] [Related]

  • 7. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
    Chen GH, Wu DP, Sun AN, Yang MZ, Wang Y, Tang XW, Chang HR, Feng YF, Zhu ZL.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug 01; 29(8):526-30. PubMed ID: 19112915
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L, Reich S, Slavin S.
    Cytokines Cell Mol Ther; 1999 Sep 01; 5(3):145-52. PubMed ID: 10641572
    [Abstract] [Full Text] [Related]

  • 9. [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice].
    Wang SB, Guo KY, Hu DM, Yin B.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun 01; 26(6):810-3. PubMed ID: 16793606
    [Abstract] [Full Text] [Related]

  • 10. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ, Thompson JS, Jennings CD, Brown SA.
    Transplantation; 1995 Oct 27; 60(8):821-7. PubMed ID: 7482742
    [Abstract] [Full Text] [Related]

  • 11. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Oct 27; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 12. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, Drobyski WR.
    Biol Blood Marrow Transplant; 2003 Dec 27; 9(12):742-52. PubMed ID: 14677113
    [Abstract] [Full Text] [Related]

  • 13. Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
    Nagler A, Ohana M, Alper R, Doviner V, Sherman Y, Rabbani E, Engelhardt D, Ilan Y.
    Bone Marrow Transplant; 2003 Aug 27; 32(4):363-9. PubMed ID: 12900772
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.